Global Dermatologicals Market Statistics, Development and Growth 2021
COVID-19 will not have a significant impact on growth in value sales of dermatologicals in Serbia during 2020. Value sales growth had already slowest to its lowest level in many years during 2019, due in large part to deteriorating economic conditions, and its growth rate will be unchanged in 2020. However, it is plausible that, in the absence of COVID-19, 2020 would have seen a modest rebound in value sales growth in dermatologicals. Many of these products are quite expensive for many consumers...
Euromonitor International's Dermatologicals in Serbia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Table ofContent
KEY DATA FINDINGS
2020 IMPACT
After a sluggish 2019, COVID-19 will delay
recovery in value sales growth in dermatologicals
Beiersdorf (Serbia) doo retains leadership due
to its dominance of nappy (diaper) rash treatments
Demand for topical and vaginal antifungals and
antipruritics boosted as stigma regarding their use fades
RECOVERY AND OPPORTUNITIES
International players with significant
marketing budgets likely to grow their value sales
Private label set to gain traction
Chemists/pharmacies will continue to lose value
share
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category:
Value 2015-2020
Table 2 Sales of Dermatologicals by Category: %
Value Growth 2015-2020
Table 3 NBO Company Shares of Dermatologicals:
% Value 2016-2020
Table 4 LBN Brand Shares of Dermatologicals: %
Value 2017-2020
Table 5 Forecast Sales of Dermatologicals by
Category: Value 2020-2025
Table 6 Forecast Sales of Dermatologicals by
Category: % Value Growth 2020-2025
EXECUTIVE SUMMARY
COVID-19 impact on consumer health
COVID-19 country impact
Company response
Retailing shift
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods
and Medical Services: Value 2015-2020
Table 8 Life Expectancy at Birth 2015-2020
MARKET DATA
Table 9 Sales of Consumer Health by Category:
Value 2015-2020
Table 10 Sales of Consumer Health by Category:
% Value Growth 2015-2020
Table 11 NBO Company Shares of Consumer Health:
% Value 2016-2020
Table 12 LBN Brand Shares of Consumer Health: %
Value 2017-2020
Table 13 Penetration of Private Label by
Category: % Value 2015-2020
…... continued
CONTACT
DETAILS :
+44 203 500 2763
+1 62 825 80070
971 0503084105
Comments
Post a Comment